Skip to main content
. 2022 Jul 22;16:813075. doi: 10.3389/fnins.2022.813075

TABLE 1.

Comparison of clinical and demographic characteristics between patients with MDD and HCs, responders, and non-responders.

Group MDD
(n = 63)
HCs
(n = 30)
p-value Responders
(n = 36)
Non-responders
(n = 27)
p-value
Age (years, mean ± SD) 28.34 ± 8.63 29.23 ± 6.59 0.621 29.86 ± 8.02 26.33 ± 9.14 0.109
Sex, n (%) 0.878
Male 20 (31.7) 10 (33.3) 10 (27.8) 10 (37.0)
Female 43 (68.3) 20 (66.7) 26 (72.2) 17 (63.0)
Marital status, n (%) 0.954 0.080
Single 29 (46.0) 14 (46.7) 20 (55.6) 9 (33.3)
Married 34 (54.0) 16 (53.3) 16 (44.4) 18 (66.7)
Family history, n (%)
Yes 12 (19.0) NA 7 (19.4) 5 (18.5) 0.926
No 51 (81.0) NA 29 (80.6) 26 (81.5)
BMI (mean ± SD) 21.67 ± 3.91 21.49 ± 2.23 0.815 21.93 ± 3.70 21.33 ± 4.23 0.554
Smoking 0.389
Yes 11 (17.5) 7 (23.3) 0.503 5 (13.9) 6 (22.2)
No 52 (82.5) 23 (76.7) 31 (86.1) 21 (77.8)
Drinking 0.195
Yes 22 (34.9) 6 (20.0) 15 (41.7) 7 (25.9)
No 41 (65.1) 24 (80.0) 0.143 21 (58.3) 20 (74.1)
HAMD baseline 28.31 ± 7.58 NA 26.94 ± 7.73 30.14 ± 7.11 0.097
HAMA baseline 18.75 ± 7.79 NA 20.06 ± 8.84 17.00 ± 5.84 0.125
Antidepressant# (mg/day) 42.33 ± 11.88 NA 43.04 ± 11.15 41.39 ± 12.94 0.589

HAMD, Hamilton Depression Rating Scale; HAMA, Hamilton Anxiety Rating Scale; NA, not applicable; MDD, major depressive disorder; HCs, healthy controls; SD, standard deviation; BMI, body mass index.

#Fluoxetine-equivalent dose of antidepressant medication.